Liwen Wang

Associated Articles

World’s first Drug to Inhibit ITK and BTK for GvHD & Autoimmune Disease

World’s first Drug to Inhibit ITK and BTK for GvHD & Autoimmune Disease

A Korean biotech claims its DWP213388 is the world’s first autoimmune disease treatment candidate and experimental drug to inhibit both interleukin-2-inducible T-cell kinase (ITK) and Bruton’s tyrosine kinase (BTK)—both targets for immune cell activation. The sponsor...

MD Anderson Cancer Center Top Medical Executive Confirmed to Run the FDA

MD Anderson Cancer Center Top Medical Executive Confirmed to Run the FDA

MD Anderson Cancer Center chief medical executive Stephen Hahn has been confirmed by the U.S. Senate as FDA commissioner. On December 12, the Senate voted 72-18 to confirm Dr. Hahn. He will become the 24th FDA commissioner, succeeding Scott Gottlieb. He has served MD...

Australian Medical Device Tech Moves into Clinical Trials

Australian Medical Device Tech Moves into Clinical Trials

Australian researchers that developed a simple eye test to detect signs of Alzheimer’s disease have secured funding to commercialize their technology—to take from lab to the eye clinic. Australia’s Centre for Eye Research recently incubated the Enlighten Imaging, an...

subscribe

CNS Summit
subscribe
Source:

Pin It on Pinterest